Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.
about
Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and TreatmentNovel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat modelAcute viral myocarditisHLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathyMast cell inhibition attenuates myocardial damage, adverse remodeling, and dysfunction during fulminant myocarditis in the ratRole of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis.Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy.Histopathological diagnosis of myocarditis in a dengue outbreak in Sri Lanka, 2009.The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathiesB-cell epitope spreading is a critical step for the switch from C-protein-induced myocarditis to dilated cardiomyopathy.Therapeutic left ventricular assist device and apheresis on dilated cardiomyopathy.Cardiac biomarkers in the intensive care unitCardiomyopathies.Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart TransplantationInnate and acquired immunity in the pathogenesis of Chagas disease.Differences in virus prevalence and load in the hearts of patients with idiopathic dilated cardiomyopathy with and without immune-mediated inflammatory diseasesAutoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies.Localization of CD8 T cell epitope within cardiac myosin heavy chain-α334-352 that induces autoimmune myocarditis in A/J miceAutoimmunity in coxsackievirus B3 induced myocarditis.Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice.STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy.The roles of selenium and mercury in the pathogenesis of viral cardiomyopathy.How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Usefulness of immunosuppression for giant cell myocarditis.Atrial tachycardia provoked in the presence of activating autoantibodies to β2-adrenergic receptor in the rabbit.Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.Pathological autoantibodies in cardiomyopathy.Effects of preexisting autoimmunity on heart graft prolongation after donor-specific transfusion and anti-CD154.Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivoThe importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy.Immune modulation in heart failure: past challenges and future hopes.Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability.Regulation of the immune response during infectious myocarditis.Acute myocarditis mimicking ST-elevation myocardial infarction: A case report and review of the literature.Cardiac Autoimmunity: Myocarditis.The therapeutic potential of immune therapy in idiopathic dilated cardiomyopathy.A humanized HLA-DR4 mouse model for autoimmune myocarditis.Interferon-γ causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditisDendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity.
P2860
Q26744257-A8C5A118-19C7-4B2D-83FC-03EE9C6548A7Q27315858-B3A7D451-AFF9-49EC-BEA6-6429B395AF30Q27486698-59538EF0-5480-471B-8D62-114F6AB3FEF7Q28078313-52E0F67B-2EEE-4560-9444-4CD72A86E421Q30414170-7E1714D5-751F-46F1-B081-51E4B5D8F7FDQ30573820-C04826A7-3A27-4B8E-B194-CF8C5652DCA4Q33813731-EBD032F4-F07B-4958-8243-D4CBF8908674Q33974343-012C0BBF-4445-4E25-B57C-F8BE01EE2CEAQ34418753-0BBBE22B-280E-4E50-A489-624851D08693Q35026108-5B997515-301C-4B16-A394-EFD1D7B96CA1Q35570461-63491ABF-2F87-455C-9F54-F89B1FE418A7Q35666574-06226397-FC5A-4A28-97A5-43632E9FD1BFQ35856435-254C5DE4-C60C-4534-9534-CB37DE9FDEC3Q35934767-0F591168-2D27-4D65-B0DF-C5E4DE13C2A1Q35954030-E388240B-B27D-431E-A1C5-337F28C6DE86Q35994773-1A04A691-7A1A-4F74-B852-BA22777E9505Q36154780-F515BD79-0381-42F7-A35B-8075D83A9157Q36283411-FA9C21FF-B2D6-4EBE-9D9D-44562700D2A0Q36307488-7C51D7A6-5551-43D2-80F2-0BE511E2BBB1Q36385481-9749B525-F548-4655-ACDB-AFC37AEF2281Q36616874-4A3DE79F-5C7A-4050-9E02-D62405399FC2Q36771328-F6778D70-2EF0-4FBB-9F0D-8B4D99EB4756Q36900783-3A9172C5-62C7-4503-BBFE-66263C1ED1A9Q37004826-BFB55379-3008-4176-9796-D8B072003793Q37037055-E40520AA-B9C8-4163-8A53-C858F37A13FDQ37045274-09F81604-2224-4EBB-8D5C-F2C23FA66BEAQ37051232-BF990F47-666E-492C-82BE-3A828084B94CQ37264371-5469565C-D5BD-4B6B-8462-34EDB654563AQ37423395-76F9B904-9EB6-430D-87E3-F1D7DB6458EAQ37567882-867F8234-FEC4-4C12-8B67-5E85D046011FQ37678209-7F7DDB40-EBDE-4F8C-81B0-54360BE3F9C4Q37827408-C42E9FC2-C4EE-4531-84BB-02127B141B76Q37871924-86A82633-A07C-4E39-93C0-6C848D859AB3Q38180743-ADFF1B6F-F6AF-4CDC-A9BC-92500225128DQ38654434-0786CA73-4962-436C-B17F-BA533A1DCCD7Q40138726-02DFFB4B-7C76-48CA-AF75-34002B2094D7Q40393628-9ABB3641-101B-46E0-B31A-EF634F22D1CCQ41919872-C7DFC187-40BC-403A-AF39-AE358974A7A4Q42109729-94EC4168-05A5-4717-AE5D-783656964F32Q43996020-2F75B2B9-21B5-4CE8-9039-3D46DE5DD400
P2860
Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Circulating cardiac autoantibo ...... tic and clinical significance.
@ast
Circulating cardiac autoantibo ...... tic and clinical significance.
@en
type
label
Circulating cardiac autoantibo ...... tic and clinical significance.
@ast
Circulating cardiac autoantibo ...... tic and clinical significance.
@en
prefLabel
Circulating cardiac autoantibo ...... tic and clinical significance.
@ast
Circulating cardiac autoantibo ...... tic and clinical significance.
@en
P2093
P2860
P1476
Circulating cardiac autoantibo ...... etic and clinical significance
@en
P2093
Alida L P Caforio
Francesco Tona
William J McKenna
P2860
P304
P356
10.1016/S1388-9842(02)00010-7
P577
2002-08-01T00:00:00Z